| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.14 | 4e-05 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.14 | 4e-05 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-05 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.14 | 8e-05 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-05 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0001 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.21 | 0.0002 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |